2,6-二异丙基苯硼酸 | 363166-79-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2,6-二异丙基苯硼酸
• 中文别名: 2-(3-异丙基苯基)丙基硼酸
• 英文名称: (2,6-diisopropylphenyl)boronic acid
• 英文别名: 2,6-Diisopropylphenylboronic acid；[2,6-di(propan-2-yl)phenyl]boronic acid
• CAS: 363166-79-4
• 化学式: C₁₂H₁₉BO₂
• mdl: MFCD16876786
• 分子量: 206.093
• InChiKey: UPXGMXMTUMCLGD-UHFFFAOYSA-N

物化性质

• 熔点：
  167-172°C
• 沸点：
  327.5±52.0 °C(Predicted)
• 密度：
  0.99±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.03
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2931900090
• 危险性防范说明：
  P280,P305+P351+P338
• 危险性描述：
  H302
• 储存条件：
  2-8°C

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 2,6-Diisopropylphenylboronic acid
CAS-No. : 363166-79-4
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C12H19BO2
Molecular Weight : 206,09 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, Borane/boron oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
No special environmental precautions required.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 167 - 172 °C
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density 7,12 - (Air = 1.0)
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 3,64
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  2,6-二异丙基苯硼酸 在 对苯醌 、 potassium hydroxide 作用下， 以 水 为溶剂， 反应 30.0h， 以75%的产率得到丙泊酚
  参考文献：
  名称：

  Benzoquinone-Promoted Aerobic Oxidative Hydroxylation of Arylboronic Acids in Water

  摘要：

  A general and efficient aerobic oxidative hydroxylation of arylboronic acids promoted by benzoquinone in water was realized, and provided phenols in 72-95% yields for 20 examples. The main advantages of this protocol are the use of water as solvent in the presence of a catalytic amount of benzoquinone, and metal-free conditions.

  DOI：

  10.1055/s-0033-1338571
• 作为产物：
  描述：

  (2,6-diisopropylphenyl)boronic acid dimethyl ester 在 盐酸 作用下， 以 四氢呋喃 、 水 为溶剂， 以1.12 g的产率得到2,6-二异丙基苯硼酸
  参考文献：
  名称：

  Structure-Based Approach to the Development of Potent and Selective Inhibitors of Dihydrofolate Reductase from Cryptosporidium

  摘要：

  Cryptosporidiosis is an emerging infectious disease that can be life-threatening in ail immune-compromised individual and causes gastrointestinal distress lasting up to 2 weeks in an immune-competent individual. There are few therapeutics available for effectively treating this disease. We have been exploring dihydrofolate reductase (DHFR) as a potential target in Cryptosporidium. On the basis of the structure of the DHFR enzyme from C. hominis, we have developed a novel scaffold that led to the discovery of potent (38 nM) and efficient inhibitors of this enzyme. Recently, we have advanced these inhibitors to the next stage of development. Using the Structures of both the protozoal and human enzymes. we have developed inhibitors with nanomolar potency (1.1 nM) against the pathogenic enzyme and high levels (1273-fold) of selectivity over the human enzyme.

  DOI：

  10.1021/jm8009124

文献信息

• [EN] LUMINESCENT DIAZABENZIMIDAZOLE CARBENE METAL COMPLEXES<br/>[FR] COMPLEXES DIAZABENZIMIDAZOLE CARBÈNE-MÉTAL LUMINESCENTS
  申请人：BASF SE

  公开号：WO2015014835A1

  公开（公告）日：2015-02-05

  The present invention relates to metal-carbene complexes of the general formula (I), where variable M is Ir or Pt and that are characterized by variable R being a group of formula (a). The complexes are used in organic electronic devices, especially OLEDs (Organic Light-Emitting Diodes), illuminating elements, stationary visual display units and in material layers as emitter, charge transport material and/or charge or exiton blocker.

  本发明涉及通式（I）的金属-卡宾配合物，其中变量M是Ir或Pt，并且其特征在于变量R是具有结构式（a）的基团。这些配合物用于有机电子设备，特别是OLED（有机发光二极管）、照明元件、固定视觉显示单元，以及作为发射体、载流子传输材料和/或载流子或激子阻挡层的材料层中。
• Catalytic Hydrosilylation of Carbonyl Compounds with Zinc(II) Acetate: Asymmetric Induction Collaborated with N₂S₂ Ligands
  作者：Hisao Nishiyama、Tomohiko Inagaki、Yoko Yamada、Le Thanh Phong、Akihiro Furuta、Jun-ichi Ito

  DOI：10.1055/s-0028-1087663

  日期：——

  Zinc acetate proved to be an efficient catalyst for hydro-silylationof ketones and aldehydes in the combination with (EtO) 2 MeSiH,and a good to excellent asymmetric induction was observed in thepresence of chiral N 2 S 2 ligands.

  乙酸锌与(EtO) 2 MeSiH 结合被证明是酮和醛氢化硅烷化的有效催化剂，并且在手性N 2 S 2 配体的存在下观察到良好至极好的不对称诱导。
• [EN] KRAS G12D INHIBITORS<br/>[FR] INHIBITEURS DE KRAS G12D
  申请人：MIRATI THERAPEUTICS INC

  公开号：WO2021041671A1

  公开（公告）日：2021-03-04

  The present invention relates to compounds that inhibit KRas G12D. In particular, the present invention relates to compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor.

  本发明涉及抑制KRas G12D的化合物。具体地，本发明涉及抑制KRas G12D活性的化合物，包括这些化合物的药物组合物以及使用方法。
• 金属錯体
  申请人：メルク パテント ゲーエムベーハー

  公开号：JP2015529637A

  公开（公告）日：2015-10-08

  本発明は、金属錯体、およびこれらの金属錯体を含む電子デバイス、特に有機エレクトロルミネッセントデバイスに関する。

  这项发明涉及金属配合物，以及包含这些金属配合物的电子器件，特别是有机电致发光器件。
• [EN] DISUBSTITUTED DIARYLOXYBENZOHETERODIAZOLE COMPOUNDS<br/>[FR] COMPOSÉS DISUBSTITUÉS DE DIARYLOXYBENZOHÉTÉRODIAZOLE
  申请人：ENI SPA

  公开号：WO2016046319A1

  公开（公告）日：2016-03-31

  Disubstituted diaryloxybenzoheterodiazole compound of general formula (1): in which: ∙ - Z represents a sulfur atom, an oxygen atom, a selenium atom; or an NR 5group in which R5 is selected from linear or branched C1-C20, preferably C1-C8, alkyl groups, or from optionally substituted aryl groups; ∙ - R1, R2 and R3 are as defined in the claims. The said disubstituted diaryloxybenzoheterodiazole compound of general formula (I) can advantageously be used as a spectrum converter in luminescent solar concentrators (LSCs) which are in turn capable of improving the performance of photovoltaic devices (or solar devices) selected, for example, from photovoltaic cells (or solar cells), photovoltaic modules (or solar modules) on either a rigid substrate or a flexible substrate.

  通用公式（1）的二取代二芳氧基苯并噻二唑化合物：其中：∙ - Z代表硫原子、氧原子、硒原子；或者一个NR 5基团，其中R5从线性或支链的C1-C20，优选C1-C8，烷基基团中选择，或者从可选择取代的芳基基团中选择；∙ - R1、R2和R3如权利要求中所定义。所述的通用公式（I）的二取代二芳氧基苯并噻二唑化合物可以优点地用作光致发光太阳能聚光器（LSCs）中的光谱转换器，这反过来能够改善选定的光伏器件（或太阳能器件）的性能，例如光伏电池（或太阳能电池）、光伏模块（或太阳能模块）在刚性基板或柔性基板上。